![](/img/cover-not-exists.png)
Modifications of plasma and platelet levels of L-DOPA and its direct metabolites during treatment with tolcapone or entacapone in patients with Parkinson’s disease
F. Blandini, G. Nappi, R. Fancellu, A. Mangiagalli, A. Samuele, G. Riboldazzi, D. Calandrella, C. Pacchetti, G. Bono, E. MartignoniVolume:
110
Language:
english
Pages:
12
DOI:
10.1007/s00702-003-0004-z
Date:
August, 2003
File:
PDF, 336 KB
english, 2003